TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein

The TRIM37 (also known as MUL) gene is located in the 17q23 chromosomal region, which is amplified in up to ∼40% of breast cancers. TRIM37 contains a RING finger domain, a hallmark of E3 ubiquitin ligases, but its protein substrate(s) is unknown. Here we report that TRIM37 mono-ubiquitinates histone H2A, a chromatin modification associated with transcriptional repression. We find that in human breast cancer cell lines containing amplified 17q23, TRIM37 is upregulated and, reciprocally, the major H2A ubiquitin ligase RNF2 (also known as RING1B) is downregulated. Genome-wide chromatin immunoprecipitation (ChIP)-chip experiments in 17q23-amplified breast cancer cells identified many genes, including multiple tumour suppressors, whose promoters were bound by TRIM37 and enriched for ubiquitinated H2A. However, unlike RNF2, which is a subunit of polycomb repressive complex 1 (PRC1), we find that TRIM37 associates with polycomb repressive complex 2 (PRC2). TRIM37, PRC2 and PRC1 are co-bound to specific target genes, resulting in their transcriptional silencing. RNA-interference-mediated knockdown of TRIM37 results in loss of ubiquitinated H2A, dissociation of PRC1 and PRC2 from target promoters, and transcriptional reactivation of silenced genes. Knockdown of TRIM37 in human breast cancer cells containing amplified 17q23 substantially decreases tumour growth in mouse xenografts. Conversely, ectopic expression of TRIM37 renders non-transformed cells tumorigenic. Collectively, our results reveal TRIM37 as an oncogenic H2A ubiquitin ligase that is overexpressed in a subset of breast cancers and promotes transformation by facilitating silencing of tumour suppressors and other genes.

[1]  Haruhiko Koseki,et al.  Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. , 2004, Developmental cell.

[2]  Miquel Salicru,et al.  Comparison of lists of genes based on functional profiles , 2011, BMC Bioinformatics.

[3]  Nissi M. Varki,et al.  Ras activation in human breast cancer , 2000, Breast Cancer Research and Treatment.

[4]  David S. Lapointe,et al.  ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data , 2010, BMC Bioinformatics.

[5]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[6]  S. Elledge,et al.  BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. , 2000, Genes & development.

[7]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[8]  C. Day,et al.  RINGs hold the key to ubiquitin transfer. , 2012, Trends in biochemical sciences.

[9]  K. V. van Holde,et al.  Homogeneous reconstituted oligonucleosomes, evidence for salt-dependent folding in the absence of histone H1. , 1989, Biochemistry.

[10]  T. Richmond,et al.  Expression and purification of recombinant histones and nucleosome reconstitution. , 1999, Methods in molecular biology.

[11]  K. Helin,et al.  Gene silencing triggers polycomb repressive complex 2 recruitment to CpG islands genome wide. , 2014, Molecular cell.

[12]  M. Hung,et al.  The role of EZH2 in tumour progression , 2011, British Journal of Cancer.

[13]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[14]  Michael B. Stadler,et al.  Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. , 2008, Molecular cell.

[15]  R. Kingston,et al.  Compaction of chromatin by diverse Polycomb group proteins requires localized regions of high charge. , 2011, Genes & development.

[16]  Michael L. Bittner,et al.  Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Reinberg,et al.  The Polycomb complex PRC2 and its mark in life , 2011, Nature.

[18]  Oliver Weichenrieder,et al.  Structure and E3‐ligase activity of the Ring–Ring complex of Polycomb proteins Bmi1 and Ring1b , 2006, The EMBO journal.

[19]  Fergus J. Couch,et al.  The 17q23 Amplicon and Breast Cancer , 2003, Breast Cancer Research and Treatment.

[20]  F. Miller,et al.  MCF10AT: a model for the evolution of cancer from proliferative breast disease. , 1996, The American journal of pathology.

[21]  O. Elemento,et al.  EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. , 2010, Blood.

[22]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[23]  M. Vidal,et al.  Role of histone H2A ubiquitination in Polycomb silencing , 2004, Nature.

[24]  James D Iglehart,et al.  Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. , 2007, Cancer cell.

[25]  D. Reinberg,et al.  Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. , 2004, Genes & development.

[26]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[27]  Achim Tresch,et al.  SoftwareSimple Tiling ARRay analysis of Affymetrix ChIP-chip data , 2010 .

[28]  Michael R. Green,et al.  An elaborate pathway required for Ras-mediated epigenetic silencing , 2007, Nature.

[29]  F. Miller,et al.  Xenograft model of progressive human proliferative breast disease. , 1993, Journal of the National Cancer Institute.

[30]  V. Thakur,et al.  Multifaceted role of EZH2 in breast and prostate tumorigenesis , 2013, Epigenetics.

[31]  Yu Cao,et al.  Inflammatory breast cancer (IBC): clues for targeted therapies , 2013, Breast Cancer Research and Treatment.

[32]  Richard A Young,et al.  CpG island structure and trithorax/polycomb chromatin domains in human cells. , 2012, Genomics.

[33]  Achim Tresch,et al.  Starr: Simple Tiling ARRay analysis of Affymetrix ChIP-chip data , 2009, BMC Bioinformatics.

[34]  Simon Kasif,et al.  Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains , 2008, PLoS genetics.

[35]  Wendy A Bickmore,et al.  Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. , 2010, Molecular cell.

[36]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[37]  Michael R. Green,et al.  Non-canonical TAF complexes regulate active promoters in human embryonic stem cells , 2012, eLife.

[38]  Michael R. Green,et al.  Transcription activation by the adenovirus E1a protein , 1989, Nature.

[39]  V. Orlando,et al.  Memories from the polycomb group proteins. , 2012, Annual review of genetics.

[40]  Vikki M. Weake,et al.  Histone ubiquitination: triggering gene activity. , 2008, Molecular cell.

[41]  Yi Zhang,et al.  Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. , 2005, Molecular cell.

[42]  N. López-Bigas,et al.  Transcriptional activation of polycomb-repressed genes by ZRF1 , 2010, Nature.

[43]  N. Tanese.  Small-scale density gradient sedimentation to separate and analyze multiprotein complexes. , 1997, Methods.

[44]  Michael R. Green,et al.  A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein , 1990, Cell.